The drug Rwanda plans to roll out is the long-acting injectable Cabotegravir (CAB-LA), an intramuscular, long-acting form of PrEP. The first two injections are administered four weeks apart, followed ...
An outbreak of Marburg virus — also known as “bleeding eye virus" — continues to grow in Rwanda, sparking concerns about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback